• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

C3 肾小球病概述。

Overview of C3 Glomerulopathy.

机构信息

University of Illinois College of Medicine , Peoria, IL , USA.

University of Illinois College of Medicine, Peoria, IL, USA; Associate Medical Director, Research and Development, Abbvie, Chicago, IL, USA.

出版信息

Front Pediatr. 2016 May 6;4:45. doi: 10.3389/fped.2016.00045. eCollection 2016.

DOI:10.3389/fped.2016.00045
PMID:27200326
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4858534/
Abstract

C3 glomerulopathy is an umbrella term, which includes several rare forms of glomerulonephritis (GN) with underlying defects in the alternate complement cascade. A common histological feature noted in all these GN is dominant C3 deposition in the glomerulus. In this review, we will provide an overview of the complement system as well as mediators, with an introduction to pharmaceutical agents that can alter the pathway.

摘要

C3 肾小球病是一个总称,包括几种罕见的肾小球肾炎 (GN),其根本缺陷在于替代补体级联。所有这些 GN 的一个共同组织学特征是肾小球中占主导地位的 C3 沉积。在这篇综述中,我们将提供补体系统以及介质的概述,并介绍可以改变途径的药物制剂。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73ef/4858534/03a7f6fc9a9d/fped-04-00045-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73ef/4858534/082ee05ca53a/fped-04-00045-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73ef/4858534/03a7f6fc9a9d/fped-04-00045-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73ef/4858534/082ee05ca53a/fped-04-00045-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73ef/4858534/03a7f6fc9a9d/fped-04-00045-g002.jpg

相似文献

1
Overview of C3 Glomerulopathy.C3 肾小球病概述。
Front Pediatr. 2016 May 6;4:45. doi: 10.3389/fped.2016.00045. eCollection 2016.
2
Dominant C3 glomerulopathy: new roles for an old actor in renal pathology.优势 C3 肾小球病:肾脏病理学中老演员的新角色。
J Nephrol. 2018 Aug;31(4):503-510. doi: 10.1007/s40620-017-0458-y. Epub 2017 Nov 18.
3
C4d as a Diagnostic Tool in Proliferative GN.C4d作为增殖性肾小球肾炎的诊断工具
J Am Soc Nephrol. 2015 Nov;26(11):2852-9. doi: 10.1681/ASN.2014040406. Epub 2015 May 19.
4
C4d at Crossroads Between Post-Infectious Glomerulonephritis and C3 Glomerulopathy.C4d处于感染后肾小球肾炎与C3肾小球病的交叉点。
Int J Nephrol Renovasc Dis. 2021 Mar 11;14:87-95. doi: 10.2147/IJNRD.S285302. eCollection 2021.
5
Diagnosis and treatment of C3 glomerulopathy in a center of expertise.专业中心对C3肾小球病的诊断与治疗
Neth J Med. 2019 Jan;77(1):10-18.
6
Evolving complexity of complement-related diseases: C3 glomerulopathy and atypical haemolytic uremic syndrome.补体相关疾病复杂性的演变:C3 肾小球病和非典型溶血尿毒综合征。
Curr Opin Nephrol Hypertens. 2018 May;27(3):165-170. doi: 10.1097/MNH.0000000000000412.
7
Pathology of renal diseases associated with dysfunction of the alternative pathway of complement: C3 glomerulopathy and atypical hemolytic uremic syndrome (aHUS).与补体替代途径功能障碍相关的肾脏疾病的病理学:C3 肾小球病和非典型溶血尿毒综合征 (aHUS)。
Semin Thromb Hemost. 2014 Jun;40(4):416-21. doi: 10.1055/s-0034-1375701. Epub 2014 May 5.
8
Histopathology of MPGN and C3 glomerulopathies.MPGN 和 C3 肾小球病的组织病理学。
Nat Rev Nephrol. 2015 Jan;11(1):14-22. doi: 10.1038/nrneph.2014.217. Epub 2014 Dec 2.
9
The role of complement in C3 glomerulopathy.补体在C3肾小球病中的作用。
Mol Immunol. 2015 Sep;67(1):21-30. doi: 10.1016/j.molimm.2015.03.012. Epub 2015 Apr 28.
10
C3 glomerulopathy and current dilemmas.C3肾小球病与当前的困境
Clin Exp Nephrol. 2017 Aug;21(4):541-551. doi: 10.1007/s10157-016-1358-5. Epub 2016 Nov 23.

引用本文的文献

1
Diagnostic and Prognostic Comparison of Immune-Complex-Mediated Membranoproliferative Glomerulonephritis and C3 Glomerulopathy.免疫复合物介导的膜增生性肾小球肾炎与 C3 肾小球病的诊断和预后比较。
Cells. 2023 Feb 23;12(5):712. doi: 10.3390/cells12050712.
2
Endocarditis-Associated C3-Dominant Glomerulonephritis in a Patient With a Solitary Kidney.孤立肾患者的心内膜炎相关性以C3为主的肾小球肾炎
Cureus. 2022 Aug 4;14(8):e27675. doi: 10.7759/cureus.27675. eCollection 2022 Aug.
3
Infection Associated C3 Glomerulopathy Presenting as Severe Crescentic Glomerulonephritis.

本文引用的文献

1
Effectiveness of mycophenolate mofetil in C3 glomerulonephritis.霉酚酸酯在 C3 肾小球肾炎中的疗效。
Kidney Int. 2015 Nov;88(5):1153-60. doi: 10.1038/ki.2015.227. Epub 2015 Jul 29.
2
Efficacy of Targeted Complement Inhibition in Experimental C3 Glomerulopathy.靶向补体抑制在实验性C3肾小球病中的疗效
J Am Soc Nephrol. 2016 Feb;27(2):405-16. doi: 10.1681/ASN.2014121195. Epub 2015 Jun 5.
3
Histopathology of MPGN and C3 glomerulopathies.MPGN 和 C3 肾小球病的组织病理学。
感染相关性C3肾小球病表现为重症新月体性肾小球肾炎
Case Rep Nephrol. 2021 Sep 27;2021:6295543. doi: 10.1155/2021/6295543. eCollection 2021.
4
Diverse Clinical Presentations of C3 Dominant Glomerulonephritis.C3 主导型肾小球肾炎的多样临床表现
Front Med (Lausanne). 2020 Jun 30;7:293. doi: 10.3389/fmed.2020.00293. eCollection 2020.
Nat Rev Nephrol. 2015 Jan;11(1):14-22. doi: 10.1038/nrneph.2014.217. Epub 2014 Dec 2.
4
Blockade of alternative complement pathway in dense deposit disease.致密物沉积病中替代补体途径的阻断
Case Rep Nephrol. 2014;2014:201568. doi: 10.1155/2014/201568. Epub 2014 Feb 6.
5
C3 glomerulopathy: consensus report.C3 肾小球病:共识报告。
Kidney Int. 2013 Dec;84(6):1079-89. doi: 10.1038/ki.2013.377. Epub 2013 Oct 30.
6
C3 nephritic factor associated with C3 glomerulopathy in children.与儿童C3肾小球病相关的C3肾炎因子
Pediatr Nephrol. 2014 Jan;29(1):85-94. doi: 10.1007/s00467-013-2605-6. Epub 2013 Sep 26.
7
Human C3 glomerulopathy provides unique insights into complement factor H-related protein function.人类 C3 肾小球病为补体因子 H 相关蛋白的功能提供了独特的见解。
J Clin Invest. 2013 Jun;123(6):2357-60. doi: 10.1172/JCI69684.
8
Pathology after eculizumab in dense deposit disease and C3 GN.依库珠单抗治疗致密物沉积病和 C3 肾小球肾炎后的病理改变。
J Am Soc Nephrol. 2012 Jul;23(7):1229-37. doi: 10.1681/ASN.2011121186. Epub 2012 Jun 7.
9
Acquired and genetic complement abnormalities play a critical role in dense deposit disease and other C3 glomerulopathies.获得性和遗传性补体异常在致密物沉积病和其他 C3 肾小球疾病中起着关键作用。
Kidney Int. 2012 Aug;82(4):454-64. doi: 10.1038/ki.2012.63. Epub 2012 Mar 28.
10
Eculizumab for dense deposit disease and C3 glomerulonephritis.依库珠单抗治疗致密物沉积病和 C3 肾小球肾炎。
Clin J Am Soc Nephrol. 2012 May;7(5):748-56. doi: 10.2215/CJN.12901211. Epub 2012 Mar 8.